-
Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, O'Mahony L, Gao Y, Nadeau K, Akdis CA. 2020. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. https://doi.org/10.1111/all.14364
-
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang HW, Wang T, Zhang XY, Chen HL, Yu HJ, Zhang XP, Zhang MX, Wu SJ, Song JX, Chen T, Han MF, Li SS, Luo XP, Zhao JP, Ning Q. 2020. Clinical and immunologic features in severe and moderate Coronavirus disease 2019. J Clin Invest. https://doi.org/10.1172/JCI137244
-
Guo B, Rothstein TL, 2013: IL-4 upregulates Igα and Igβ protein, resulting in augmented IgM maturation and B cell receptor-triggered B cell activation[J]. J Immunol, 191, 670-677. doi: 10.4049/jimmunol.1203211
-
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B, 2020: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 395, 497-506. doi: 10.1016/S0140-6736(20)30183-5
-
Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, Sasaki T, Ohteki T, Ranieri VM, dos Santos CC, Kawaoka Y, Akira S, Luster AD, Lu B, Penninger JM, Uhlig S, Slutsky AS, Imai Y, 2013: CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin[J]. Am J Respir Crit Care Med, 187, 6-77.
-
Jia R, Liu S, Xu J, Liang X, 2020: IL16 deficiency enhances Th1 and cytotoxic T lymphocyte response against influenza a virus infection[J]. Biosci Trends, 13, 516-522.
-
León B, Ballesteros-Tato A, Lund FE, 2014: Dendritic cells and B cells: unexpected partners in Th2 development[J]. J Immunol, 193, 1531-1537. doi: 10.4049/jimmunol.1400149
-
Li CK, Wu H, Yan H, Ma S, Wang L, Zhang M, Tang X, Temperton NJ, Weiss RA, Brenchley JM, Douek DC, Mongkolsapaya J, Tran BH, Lin CL, Screaton GR, Hou JL, McMichael AJ, Xu XN, 2008: T cell responses to whole SARS coronavirus in humans[J]. J Immunol, 181, 5490-5500. doi: 10.4049/jimmunol.181.8.5490
-
Li C, Dai J, Dong G, Ma Q, Li Z, Zhang H, Yan F, Zhang J, Wang B, Shi H, Zhu Y, Yao X, Si C, Xiong H, 2019: Interleukin-16 aggravates ovalbumin-induced allergic inflammation by enhancing Th2 and Th17 cytokine production in a mouse model[J]. Immunology, 157, 257-267. doi: 10.1111/imm.13068
-
Liu P, Cai J, Jia R, Xia S, Wang X, Cao L, Zeng M, Xu J, 2020: Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19[J]. Emerg Microbes Infect, 9, 1254-1258. doi: 10.1080/22221751.2020.1772677
-
Ludvigsson JF. 2020. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. https://doi.org/10.1111/apa.15270
-
Lycke N, 1998: T cell and cytokine regulation of the IgA response[J]. Chem Immunol, 71, 209-234. doi: 10.1159/000058712
-
Marconi M, Plebani A, Avanzini MA, Maccario R, Pistorio A, Duse M, Stringa M, Monafo V, 1998: IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients[J]. Clin Exp Immunol, 112, 528-532. doi: 10.1046/j.1365-2249.1998.00589.x
-
Matricardi PM, Dal Negro RW, Nisini R. 2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol. https://doi.org/10.1111/pai.13271
-
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, 2020: COVID-19: consider cytokine storm syndromes and immunosuppression[J]. Lancet, 395, 1033-1034. doi: 10.1016/S0140-6736(20)30628-0
-
Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL. 2020. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. https://doi.org/10.3201/eid2607.200841
-
Pedersen SF, HO YC. 2020. SARS-CoV-2: a storm is raging. J Clin Invest. https://doi.org/10.1172/JCI137647
-
Qin C, Zhou LQ, Hu ZW, Zhang SQ, Yang S, Tao Y, Xie CH, Ma K, Shang K, Wang W, Tian DS. 2020. Dysregulation of immune response in patients with COVID-19 in Wuhan. China. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa248
-
Sampson DL, Fox BA, Yager TD, Bhide S, Cermelli S, McHugh LC, Seldon TA, Brandon RA, Sullivan E, Zimmerman JJ, Noursadeghi M, Brandon RB, 2017: A four-biomarker blood signature discriminates systemic inflammation due to viral infection versus other etiologies[J]. Sci Rep, 7, 2914-. doi: 10.1038/s41598-017-02325-8
-
Saxena A, Khosraviani S, Noel S, Mohan D, Donner T, Hamad AR, 2015: Interleukin-10 paradox: a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy[J]. Cytokine, 74, 27-34. doi: 10.1016/j.cyto.2014.10.031
-
Su L, Ma X, Yu H, Zhang ZH, Bian PF, Han YL, Jing S, Liu YQ, Yang C, Geng J, Zhang ZF, Gai ZT, 2020: The different clinical characteristics of corona virus disease cases between children and their families in China—the character of children with COVID-19[J]. Emerg Microbes Infect, 9, 707-713. doi: 10.1080/22221751.2020.1744483
-
Velavan TP, Meyer CG, 2020: The COVID-19 epidemic[J]. Trop Med Int Health, 25, 278-280. doi: 10.1111/tmi.13383
-
Wang F, Hou HY, Luo Y, Tang GX, Wu SJ, Huang M, Liu WY, Zhu YW, Lin Q, Mao LY, Fang MH, Zhang HL, Sun ZY. 2020. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. https://doi.org/10.1172/jci.insight.137799
-
Yamamoto M, Vancott JL, Okahashi N, Marinaro M, Kiyono H, Fujihashi K, Jackson RJ, Chatfield SN, Bluethmann H, McGhee JR, 1996: The role of Th1 and Th2 cells for mucosal IgA responses[J]. Ann N Y Acad Sci, 778, 64-71. doi: 10.1111/j.1749-6632.1996.tb21115.x
-
Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F, Wang F, Li G, Li Y, Xing L, Peng L, Yang M, Cao M, Zheng H, Wu W, Zou R, Li D, Xu Z, Wang H, Zhang M, Zhang Z, Gao GF, Jiang C, Liu L, Liu Y. 2020. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2020.04.027
-
Zhang J, Yu M, Tong S, Liu LY, Tang LV, 2020: Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China[J]. J Clin Virol, 127, 104392-. doi: 10.1016/j.jcv.2020.104392
-
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S, Hong C, Wang F, Liu Y, Wang Z, He Q, Li Z, He B, Zhang T, Fu Y, Ge S, Liu L, Zhang J, Xia N, Zhang Z. 2020. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa344